LU73680A1 - - Google Patents
Info
- Publication number
- LU73680A1 LU73680A1 LU73680A LU73680A LU73680A1 LU 73680 A1 LU73680 A1 LU 73680A1 LU 73680 A LU73680 A LU 73680A LU 73680 A LU73680 A LU 73680A LU 73680 A1 LU73680 A1 LU 73680A1
- Authority
- LU
- Luxembourg
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU73680A LU73680A1 (xx) | 1975-10-29 | 1975-10-29 | |
| US05/734,628 US4089967A (en) | 1975-10-29 | 1976-10-21 | Creatinine pyrrolidone carboxylate, pharmaceutical compositions and methods of use thereof |
| DE2648830A DE2648830C3 (de) | 1975-10-29 | 1976-10-27 | 2-Pyrrolidon-5-carbonsäuresalz des Kreatinins, Verfahren zu dessen Herstellung und dieses enthaltendes pharmazeutisches Mittel |
| GB44894/76A GB1511196A (en) | 1975-10-29 | 1976-10-28 | Creatinine pyrolidonecarboxylate |
| FR7632539A FR2329273A1 (fr) | 1975-10-29 | 1976-10-28 | Pyrrolidone carboxylate de creatinine, son procede de preparation et compositions pharmaceutiques le contenant |
| BE171874A BE847740A (fr) | 1975-10-29 | 1976-10-28 | Pyrolidone carboxylate de creatinine, son procede de preparation et compositions pharmaceutiques le contenant |
| JP51130388A JPS6021147B2 (ja) | 1975-10-29 | 1976-10-29 | ピロリドンカルボン酸クレアチニン |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU73680A LU73680A1 (xx) | 1975-10-29 | 1975-10-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU73680A1 true LU73680A1 (xx) | 1977-05-31 |
Family
ID=19728093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU73680A LU73680A1 (xx) | 1975-10-29 | 1975-10-29 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4089967A (xx) |
| JP (1) | JPS6021147B2 (xx) |
| BE (1) | BE847740A (xx) |
| DE (1) | DE2648830C3 (xx) |
| FR (1) | FR2329273A1 (xx) |
| GB (1) | GB1511196A (xx) |
| LU (1) | LU73680A1 (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL78842A0 (en) * | 1985-05-22 | 1986-09-30 | Serono Otc Sa | Piperidino-pyridine derivatives and pharmaceutical and cosmetic compositions containing them |
| JP4681132B2 (ja) * | 2001-01-29 | 2011-05-11 | 味の素株式会社 | 一酸化窒素合成酵素産生促進剤および化粧料若しくは医薬組成物 |
| US9265458B2 (en) | 2012-12-04 | 2016-02-23 | Sync-Think, Inc. | Application of smooth pursuit cognitive testing paradigms to clinical drug development |
| US9380976B2 (en) | 2013-03-11 | 2016-07-05 | Sync-Think, Inc. | Optical neuroinformatics |
| US10645967B2 (en) | 2017-08-08 | 2020-05-12 | The Clorox Company | Shelf-stable acidified aerated food emulsion |
-
1975
- 1975-10-29 LU LU73680A patent/LU73680A1/xx unknown
-
1976
- 1976-10-21 US US05/734,628 patent/US4089967A/en not_active Expired - Lifetime
- 1976-10-27 DE DE2648830A patent/DE2648830C3/de not_active Expired
- 1976-10-28 FR FR7632539A patent/FR2329273A1/fr active Granted
- 1976-10-28 BE BE171874A patent/BE847740A/xx not_active IP Right Cessation
- 1976-10-28 GB GB44894/76A patent/GB1511196A/en not_active Expired
- 1976-10-29 JP JP51130388A patent/JPS6021147B2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE2648830A1 (de) | 1977-05-05 |
| DE2648830C3 (de) | 1981-01-29 |
| FR2329273A1 (fr) | 1977-05-27 |
| JPS5254016A (en) | 1977-05-02 |
| BE847740A (fr) | 1977-04-28 |
| US4089967A (en) | 1978-05-16 |
| GB1511196A (en) | 1978-05-17 |
| FR2329273B1 (xx) | 1978-11-17 |
| DE2648830B2 (de) | 1980-05-14 |
| JPS6021147B2 (ja) | 1985-05-25 |